Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Jhonghe City, Taiwan Clinical Trials

A listing of Jhonghe City, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (12) clinical trials

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

This is a trial to evaluate use of different doses of PG2 treatment for fatigue improvement in advanced cancer patients who are under standard palliative care at hospice setting and have no further curative options available. Only patients who give consent to participate in this study and meet all other ...

Phase

0.74 miles

Learn More »

Cerebral Artery Stenosis Coronary Artery Disease and Arrhythmia

There are many reports about the association of coronary artery disease (CAD) and cerebral artery stenosis (CAS), which had been proved to induce stroke and cognition decline after the revascularization including coronary bypass surgery (CABG) or percutaneous coronary intervention. Perfusion defect on nuclear brain scan is also noted to correlate ...

Phase

1.83 miles

Learn More »

Assess the Safety and Efficacy of Nephoxil in Subjects With End Stage Renal Disease (ESRD) on Dialysis

This study is an open-label, prospective, long term, Phase IV study to assess the safety and efficacy of Nephoxil® in subjects with ESRD on dialysis.

Phase

2.01 miles

Learn More »

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Recombinant IFN alfa possesses anti-viral and immunomodulatory effects and has been shown to be effective in chronic hepatitis B [Davis et al. 1989; Bisceclie et al, 1989]. Interferon alfa is also one of the approved treatments for chronic hepatitis B. Administration of IFN alfa-2b to adults leads to disappearance of ...

Phase

3.84 miles

Learn More »

Interaction Between Nalbuphine and Morphine in PCA

1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist 2. This study was designed to investigate the interaction between nalbuphine and morphine 3. The analgesic effect and opioid-related side effects will be investigated

Phase

3.84 miles

Learn More »

Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort

This study will investigate whether switching symptomatic COPD patients from a fixed-dose combination of salmeterol/fluticasone 50/500 µg b.i.d. to a fixed dose combination of QVA149 110/50 µg o.d. leads to improved lung function and airflow. It will also assess the effect on symptom burden, breathlessness, and use of rescue medication ...

Phase

5.04 miles

Learn More »

Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding

Gastric varies (GV) rarely rupture. However should it occur, the outcome would be worse than rupture of esophageal varies (EV). Rupture of GV is characteristic of a higher rebleeding rate, a requirement for a larger amount of blood transfusion and a higher mortality. Up to date, the treatment of GV ...

Phase

5.62 miles

Learn More »

CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist

This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced Magnetic Resonance Angiography (CE-MRA) of arteries (specified vessel segments) by analyzing the rate of agreement, image quality, and diagnostic confidence between a CE-MRA based diagnosis and the diagnosis achieved from the comparator procedure IA DSA using Ultravist.

Phase

5.62 miles

Learn More »

Community-based Helicobacter Pylori Eradication

Despite the decline of global incidence, gastric cancer still affects public health substantially due to the considerable medical burden in the treatment of disease at the symptomatic stage. This fact has prompted clinicians to extend their attention from the multidisciplinary therapies to the design of preventive strategies. Gastric cancer development ...

Phase

5.62 miles

Learn More »

The Effects of Continuous Positive Airway Pressure on Overlap Syndrome

COPD patients will be disturbed by season 12 months follow up is better than 18 months

Phase

5.93 miles

Learn More »